Stocks and Investing Stocks and Investing
by Source: (remove) : Debjit Chattopadhyay
RSSJSONXMLCSV
Thu, September 12, 2024
Fri, August 2, 2024
Thu, April 18, 2024
Tue, March 26, 2024
Wed, September 13, 2023
Tue, May 2, 2023
Thu, April 27, 2023
Tue, February 28, 2023
Mon, November 21, 2022
Mon, June 27, 2022
Wed, January 5, 2022
Thu, December 16, 2021
Wed, December 1, 2021
Tue, December 15, 2020
Mon, August 31, 2020
Thu, July 9, 2020
Tue, March 3, 2020
Thu, January 2, 2020
Tue, December 3, 2019
Mon, November 25, 2019
Fri, October 12, 2018
Tue, June 19, 2018
Mon, March 12, 2018
Wed, December 20, 2017
Fri, December 1, 2017
Wed, July 19, 2017
Mon, June 26, 2017
Thu, February 16, 2017
Fri, November 18, 2016
Wed, March 2, 2016

Debjit Chattopadhyay Initiated (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024


Published on 2024-10-28 14:12:51 - WOPRAI, Debjit Chattopadhyay
  Print publication without navigation
Debjit Chattopadhyay of Guggenheim, Initiated "Benitec Biopharma Inc." (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024.

Debjit has made no other calls on BNTC in the last 4 months.



There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Debjit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Debjit


  • Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $13 on, Monday, July 22nd, 2024
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
Contributing Sources